Role of O -Linked N -Acetylglucosamine Protein Modification in Cellular (Patho)Physiology

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

• Level A · Stronger Clinical Evidence
• Level B · Emerging clinical evidence with positive signals
• Level C · Early human research exploring benefits
• Level D · Scientific groundwork from lab and animal studies
• Emerging · Emerging topic under active research

Abstract (original English)

In the mid-1980s, the identification of serine and threonine residues on nuclear and cytoplasmic proteins modified by a N -acetylglucosamine moiety ( O -GlcNAc) via an O -linkage overturned the widely held assumption that glycosylation only occurred in the endoplasmic reticulum, Golgi apparatus, and secretory pathways. In contrast to traditional glycosylation, the O -GlcNAc modification does not lead to complex, branched glycan structures and is rapidly cycled on and off proteins by O -GlcNAc transferase (OGT) and O -GlcNAcase (OGA), respectively. Since its discovery, O -GlcNAcylation has been shown to contribute to numerous cellular functions, including signaling, protein localization and stability, transcription, chromatin remodeling, mitochondrial function, and cell survival. Dysregulation in O -GlcNAc cycling has been implicated in the progression of a wide range of diseases, such as diabetes, diabetic complications, cancer, cardiovascular, and neurodegenerative diseases. This review will outline our current understanding of the processes involved in regulating O -GlcNAc turnover, the role of O -GlcNAcylation in regulating cellular physiology, and how dysregulation in O -GlcNAc cycling contributes to pathophysiological processes.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.